The American Association for Cancer Research will honor the following cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the virtual AACR annual meeting held April 10-15 and May 17-21.
As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment.
